Register Login
Register to leave comments
  • News bot June 29, 2026, 8:36 p.m.

    📋 TARSUS PHARMACEUTICALS, INC. (TARS) - Regulatory Update

    Filing Date: 2026-06-29

    Accepted: 2026-06-29 16:19:53

    Event Type: Regulatory Update

    Event Details:

    TARSUS PHARMACEUTICALS, INC. (TARS) Announces Regulatory Update TARSUS PHARMACEUTICALS, INC. (TARS) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    🔬 Clinical Development Pipeline (TARSUS PHARMACEUTICALS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Intrarectal ıce application Other Approved Prostate Cancer ClinicalTrials.gov
    Acupressure Other Approved Anxiety ClinicalTrials.gov
    Mobile application Other Approved Prostate Cancer (Post Prostatectomy) ClinicalTrials.gov
    Gel nail application Other Approved Healthy Individuals ClinicalTrials.gov
    Stress Ball Other Approved Ureteroscopy ClinicalTrials.gov
    Virtual Reality Other Approved Ureteroscopy ClinicalTrials.gov
    Education Other Approved Retrograde Intrarenal Surgery ClinicalTrials.gov
    4-7-8 breathing technique Other Approved 4-7-8 Breathing Technique ClinicalTrials.gov
    Placebo Other Phase PHASE2 Lyme Disease ClinicalTrials.gov
    TP-05 (lotilaner) High Dose Other Phase PHASE2 Lyme Disease ClinicalTrials.gov
    TP-05 (lotilaner) Low Dose Other Phase PHASE2 Lyme Disease ClinicalTrials.gov
    massage Other Approved Labor and Delivery ClinicalTrials.gov
    Video-based Education Other Approved Parental Stress ClinicalTrials.gov
    routine care Other Approved Parental Stress ClinicalTrials.gov
    Short Film-Based Education Other Approved Parental Stress ClinicalTrials.gov
    controlled (automatic) massage Other Approved Massage ClinicalTrials.gov
    TP-05 (lotilaner oral capsules) Other Phase PHASE1 Healthy ClinicalTrials.gov
    Observational Tests Other Preclinical COVID-19 Pandemic ClinicalTrials.gov
    TP-05 (lotilaner oral), low-fat group Other Phase PHASE1 Healthy ClinicalTrials.gov
    TP-05 (lotilaner oral), high-fat group Other Phase PHASE1 Healthy ClinicalTrials.gov
    TP-05 (lotilaner oral), fasted group Other Phase PHASE1 Healthy ClinicalTrials.gov
    Scheduled training group Other Approved Day Surgery ClinicalTrials.gov
    Group watching video Other Approved Day Surgery ClinicalTrials.gov
    Refrigerated gel ice Other Approved Children, Only ClinicalTrials.gov
    Cold spray Other Approved Children, Only ClinicalTrials.gov
    Vehicle control gel Other Phase PHASE2 Papulopustular Rosacea ClinicalTrials.gov
    Lotilaner Gel, 2.0% Other Phase PHASE2 Papulopustular Rosacea ClinicalTrials.gov
    Matching card group Other Approved Fear ClinicalTrials.gov
    Projector colleyscope group Other Approved Fear ClinicalTrials.gov
    Mobile Application Game Training Other Approved Asthma in Children ClinicalTrials.gov
    Shot Blocker Other Approved Pain, Acute ClinicalTrials.gov
    Helfer skin tap technique Other Approved Pain, Acute ClinicalTrials.gov
    TP-03 Vehicle Other Phase PHASE3 Blepharitis ClinicalTrials.gov
    TP-03 Other Phase PHASE3 Blepharitis ClinicalTrials.gov
    TP-03, 0.25% Other Phase PHASE2 Blepharitis ClinicalTrials.gov
    The peer trainer will be subjected to assertiveness training based on dating violence and internalized misogyny by the researcher for 2 hours a day for 5 days. Other Approved Dating Violence ClinicalTrials.gov
    Assessment Other Preclinical Neck Pain ClinicalTrials.gov
    Buzzy Other Approved Child, Only ClinicalTrials.gov
    Helfer Skin Tap Other Approved Child, Only ClinicalTrials.gov
    Closed-system catheter Other Approved Child, Only ClinicalTrials.gov
    Vehicle of TP-03 Other Phase PHASE2 Meibomian Gland Dysfunction ClinicalTrials.gov
    TP-03 (Lotilaner Ophthalmic Solution), 0.25% Other Phase PHASE1 Healthy ClinicalTrials.gov
    delivery of the placenta Other Approved Placenta Abruptio ClinicalTrials.gov
    cord clamping Other Approved Placenta Abruptio ClinicalTrials.gov
    Uteratonic administration Other Approved Placenta Abruptio ClinicalTrials.gov
    Reminder message Other Approved Breast Cancer ClinicalTrials.gov
    Placebo Comparator Other Phase PHASE2 Healthy Volunteer ClinicalTrials.gov
    High Dose TP-05 Other Phase PHASE2 Healthy Volunteer ClinicalTrials.gov
    Low Dose TP-05 Other Phase PHASE2 Healthy Volunteer ClinicalTrials.gov
    warm gel pad Other Approved Pain ClinicalTrials.gov
    Ice pack Other Approved Pain ClinicalTrials.gov
    Cartoon Other Approved Fear ClinicalTrials.gov
    Playing with toy nebulizer Other Approved Fear ClinicalTrials.gov
    Projector Kaleidoscope Other Approved Anxiety and Fear ClinicalTrials.gov
    Family Information Training Other Approved Burns ClinicalTrials.gov
    Functional balance training Other Approved Older People ClinicalTrials.gov
    Functional reaction balance training Other Approved Older People ClinicalTrials.gov
    Standart medical treatment Drug Approved High Intensity Interval Training ClinicalTrials.gov
    Low-volume, high-intensity interval training Other Approved High Intensity Interval Training ClinicalTrials.gov
    vibration and ice group Other Approved Fear ClinicalTrials.gov
    vibration group Other Approved Fear ClinicalTrials.gov
    cold application group Other Approved Fear ClinicalTrials.gov
    Mother voice Other Approved Pain ClinicalTrials.gov
    Breast milk odour Other Approved Pain ClinicalTrials.gov
    phototherapy treatment Drug Approved Newborn; Vitality ClinicalTrials.gov
    Mother's Breast Milk Smell Other Approved Newborn; Vitality ClinicalTrials.gov
    Mother's Smell Other Approved Newborn; Vitality ClinicalTrials.gov
    Mindfulness-Based Self-Compassion Training Other Approved Menopausal; Crisis ClinicalTrials.gov
    FUNCTIONAL STROKE TRAİNİNG Other Approved Stroke ClinicalTrials.gov
    THERA-TRAINER BASED EXERCISES Other Approved Stroke ClinicalTrials.gov
    The midwife-led continuous care model (MLCC) Other Approved Birth, First ClinicalTrials.gov
    To inform Other Approved Ultrasound ClinicalTrials.gov
    Vehicle control Other Phase PHASE4 Demodex Blepharitis ClinicalTrials.gov
    Lotilaner ophthalmic solution, 0.25% Other Phase PHASE4 Demodex Blepharitis ClinicalTrials.gov
    Teach Back Education Other Approved Healthy ClinicalTrials.gov
    ShotBlocker Group Other Approved Newborn ClinicalTrials.gov
    Buzzy®.Group Other Approved Newborn ClinicalTrials.gov
    Group with Bed Head Height 45° Other Approved Newborn Preterm ClinicalTrials.gov
    Group with Bed Head Height 30° Other Approved Newborn Preterm ClinicalTrials.gov
    Puzzle education group Other Approved Education Nursing ClinicalTrials.gov
    Cornell Note Taking education group Other Approved Education Nursing ClinicalTrials.gov
    Peer education group Other Approved Nursing Education ClinicalTrials.gov
    Heated socks to be developed with wearable technology Other Approved Wearable Technology ClinicalTrials.gov
    Pilates and Kinesiotape Other Approved Neck Pain ClinicalTrials.gov
    Pilates Other Approved Neck Pain ClinicalTrials.gov
    virtual reality glasses Other Approved Fear Anxiety ClinicalTrials.gov
    kaleidoscope Other Approved Fear Anxiety ClinicalTrials.gov
    gum chewing Other Approved Postsurgical Ileus ClinicalTrials.gov
    video based exercise Other Approved Amyotrophic Lateral Sclerosis ClinicalTrials.gov
    Short film video Other Approved Anxiety and Fear ClinicalTrials.gov
    short video film Other Approved Fear ClinicalTrials.gov
    music Other Approved Pain ClinicalTrials.gov
    Low Volume Upper Extremity Exercises Training Other Approved Sedentary Behavior ClinicalTrials.gov
    High-Volume Upper Extremity Exercises Training Other Approved Sedentary Behavior ClinicalTrials.gov
    Conventional Functional Balance Training Other Approved Aging ClinicalTrials.gov
    Exergame-based Balance and Foot Muscle Training Other Approved Aging ClinicalTrials.gov
    Toy Group Other Approved Child ClinicalTrials.gov
    Side kangaroo position group Other Approved Newborn Care ClinicalTrials.gov
    Vehicle Other Phase PHASE2 Ocular Rosacea ClinicalTrials.gov
    lotilaner Other Phase PHASE2 Ocular Rosacea ClinicalTrials.gov
    Warm Gel Pad Group Other Approved Drain ClinicalTrials.gov
    Intrarectal ıce Other Approved TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY ClinicalTrials.gov
    Tang-min-ling pills high dosage DRUG Phase PHASE2 Diabetes Mellitus, Type 2 ClinicalTrials.gov
    Tang-min-ling pills low dosage DRUG Phase PHASE2 Diabetes Mellitus, Type 2 ClinicalTrials.gov
    Warfarin; Dantonic DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    T89(Dantonic) DRUG Phase PHASE1 Stable Angina ClinicalTrials.gov
    tiapride DRUG Phase PHASE3 Tic Disorder ClinicalTrials.gov
    5LGr DRUG Phase PHASE3 Tic Disorder ClinicalTrials.gov
    T89 DRUG Phase PHASE2 Angina Pectoris ClinicalTrials.gov
    T89 Group C DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Placebo Group C DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    T89 Group B DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Placebo Group B DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Placebo Group A DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    T89 Group A DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Sanqi+Bingpian DRUG Phase PHASE3 Angina Pectoris ClinicalTrials.gov
    T89 Low dose DRUG Phase PHASE3 Angina Pectoris ClinicalTrials.gov
    T89 high dose DRUG Phase PHASE3 Angina Pectoris ClinicalTrials.gov
    Ginsenoside H dripping pills+Placebo DRUG Phase PHASE2 Non-small Cell Lung Cancer (NSCLC) ClinicalTrials.gov
    Ginsenoside H dripping pills DRUG Phase PHASE2 Non-small Cell Lung Cancer (NSCLC) ClinicalTrials.gov
    Compound danshen dripping pills DRUG Phase PHASE3 Non-proliferative Diabetic Retinopathy ClinicalTrials.gov
    Placebo capsule DRUG Phase PHASE2 Acute Mountain Sickness (AMS) ClinicalTrials.gov
    T89 capsule DRUG Phase PHASE2 Acute Mountain Sickness (AMS) ClinicalTrials.gov
    deferred stenting group (two-step strategy) PROCEDURE Approved Coronary Artery Disease ClinicalTrials.gov
    immediate stenting group(one-step strategy) PROCEDURE Approved Coronary Artery Disease ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: TARSUS PHARMACEUTICALS, INC.
    • Ticker Symbol: TARS

Search

News categories